Smoking abstinence 1 year after acute coronary syndrome: follow-up from a randomized controlled trial of varenicline in patients admitted to hospital

Smoking cessation after hospitalization for myocardial infarction or cardiac surgery: Assessing patient interest, confidence, and physician prescribing practices

“…However, our study also showed that there is currently a large treatment gap in the prescription of SCM and NRT provided to hospitalized smokers, even if they indicate interest in its use. For instance, previous literature indicates that when initiated in‐hospital following acute coronary syndrome, Varenicline significantly increases SC ; however, in the present study, varenicline was only prescribed to one (1.2%) patient. Overall, in our study, only about one‐third (37%) of the patients were prescribed NRT or SCM while inpatient or at discharge.…”

“…However, our findings are consistent with previous literature among the general (noncardiac) population, which shows that a large majority of smokers are interested in quitting smoking and motivated to do so during hospitalization. [14][15][16][17][18] This may be because smokers may be more motivated to quit during hospitalization due to the increase in personal relevance (ie, sentinel event) their illness or symptoms provide. 17 Unfortunately, despite patients' interest in quitting and the fact that SC is the single most effective lifestyle change a patient can make after myocardial infarction, up to 60% of patients who smoke will eventually relapse within 1 year of hospitalization, most of whom will do so within the first 3 weeks following discharge.…”

“…[14][15][16][17][18] This may be because smokers may be more motivated to quit during hospitalization due to the increase in personal relevance (ie, sentinel event) their illness or symptoms provide. 17 Unfortunately, despite patients' interest in quitting and the fact that SC is the single most effective lifestyle change a patient can make after myocardial infarction, up to 60% of patients who smoke will eventually relapse within 1 year of hospitalization, most of whom will do so within the first 3 weeks following discharge. 1,[14][15][16][17]19 These two facts only reinforce the notion that starting treatment during hospitalization is critical.…”

“…17 Unfortunately, despite patients' interest in quitting and the fact that SC is the single most effective lifestyle change a patient can make after myocardial infarction, up to 60% of patients who smoke will eventually relapse within 1 year of hospitalization, most of whom will do so within the first 3 weeks following discharge. 1,[14][15][16][17]19 These two facts only reinforce the notion that starting treatment during hospitalization is critical. Furthermore, SC support, such as SCM and NRT, are readily available throughout a patient's hospital stay.…”

Smoke cessation in cardiovascular pathology from the perspective of evidence-based medicine

“…Больные, которые не смогли отказаться от ТК при лечении варениклином, в 67,4% случаев снизили ежедневное потребление сигарет более, чем на 50% [37]. Дальнейшее наблюдение за этими пациентами в течение года показало, что варениклин был эффективен для прекращения курения в этой группе пациентов высокого риска, хотя 60% пациентов, которые получали лечение варениклином, возвращались к курению после госпитализации в течение года [38].…”